Officials of the German drugmaker are on a two-day visit, meeting with startups in biotech and digital health to check out investments and partnerships
If the Talicia drug to combat H. pylori bacterial infection gets approved, commercial launch is planned for the fourth quarter of 2019, Israeli firm says
Recent comments